NCT04120714 Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming
| NCT ID | NCT04120714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire Dijon |
| Condition | Pathological Use of Internet Games |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-01-06 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2020-01-06 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Internet has grown considerably in the last twenty years, and as a result, cases of excessive iinterney use have emerged. These cases, which have clinical similarities with substance addiction, involve the various activities related to the Internet (online gambling, discussion forums, online networking, e-mail, pornography, shopping, etc.). However, to date, only the pathological use of Internet gaming (PUIG) is referenced in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5, section III). In PUIG, an individual loses control when gambling online. He/she typically spends 8 to 10 hours on this activity, sometimes without eating or sleeping. Usual obligations, such as school or work, or family obligations are neglected. PUIG can cause great psychological and social suffering. Neurological complications (epilepsy) and deaths (cardiac arrest) related to PUIG have also been reported. These situations are all the more dramatic because they often affect adolescents and young adults. In Asia, PUIG has become a public health problem. To date, no treatment has been validated for this disorder. Non-invasive brain stimulation (NIBS) techniques can modulate neural activity in the dorsolateral prefrontal cortex (DLPFC). This modulation makes it possible to reduce addictive behaviours through different mechanisms (reduction of craving, impulsivity, and decision-making disorders). These techniques could be effective for PUIG.
Eligibility Criteria
Inclusion Criteria: * Patient aged ≥ 12 years old * Patient and/or parents who have given oral consent * Patient with PUIG (DSM-5 criteria) * Patient that is motivated and willing to reduce or stop internet gaming Exclusion Criteria: * a person who is not affiliated to or not a beneficiary of a social security scheme * Patient with severe chronic psychiatric comorbidity (schizophrenia, paranoia, chronic hallucinatory psychosis) and bipolar disorder types I and II * Patient with a gambling addiction * Patient who has had a recent change (\< 1 month) in the prescription of psychotropic treatment * Patient with an addiction to a psychoactive substance other than tobacco * Patient receiving psychiatric care without consent or legal protection (guardianship, curatorship) * Minor patient without parental consent for care * Patient with severe heart, kidney, liver or lung failure * Patient with a contraindication to the practice of tDCS: metal parts, medical devices implanted in the brain * Pregnancy or breastfeeding in progress (negative pregnancy test) * Patient unable to commit to a three-month follow-up
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04120714 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Pathological Use of Internet Games. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04120714 currently recruiting?
Yes, NCT04120714 is actively recruiting participants. Contact the research team at benoit.trojak@chu-dijon.fr for enrollment information.
Where is the NCT04120714 trial being conducted?
This trial is being conducted at Dijon, France.
Who is sponsoring the NCT04120714 clinical trial?
NCT04120714 is sponsored by Centre Hospitalier Universitaire Dijon. The trial plans to enroll 50 participants.